Globus Medical (GMED) Tops Q1 EPS by 20c ; Offers Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street ends higher after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mailGet Alerts GMED Hot Sheet
Join SI Premium – FREE
Globus Medical (NYSE: GMED) reported Q1 EPS of $1.12, $0.20 better than the analyst estimate of $0.92. Revenue for the quarter came in at $759.85 million versus the consensus estimate of $740.34 million.
GUIDANCE:
Globus Medical sees FY2026 EPS of $4.70-$4.80, versus the consensus of $4.47. Globus Medical sees FY2026 revenue of $3.18-3.22 billion, versus the consensus of $3.2 billion.
For earnings history and earnings-related data on Globus Medical (GMED) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BillionToOne, Inc. (BLLN) Tops Q3 EPS by 23c; Offers Guidance
- Veeco Instruments (VECO) Misses Q3 EPS by 9c; Offers Guidance
- Socket Mobile (SCKT) Reports Q3 Loss of $0.09
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
